nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A novel variant in the ABCA1 gene for Tangier Disease with diffuse histiocytosis of bone marrow
|
Ramalho, Ana Rita |
|
|
19 |
2 |
p. 372-376 |
artikel |
2 |
Assessing omega-3 fatty acids–critically weighing options and relevance
|
von Schacky, Clemens |
|
|
19 |
2 |
p. 208-214 |
artikel |
3 |
Characteristics and outcomes of patients with and without statin-associated muscle symptoms treated with bempedoic acid in the CLEAR Outcomes trial
|
Laufs, Ulrich |
|
|
19 |
2 |
p. 337-347 |
artikel |
4 |
Clinical impact of ≥50% reduction of low density lipoprotein cholesterol following lipid lowering therapy on cardiovascular outcomes in patients with acute coronary syndrome
|
Fujioka, Shimpei |
|
|
19 |
2 |
p. 247-255 |
artikel |
5 |
Differential coronary heart disease risk among antihypertensive and lipid-lowering medication users versus non-users: A real-world data analysis
|
Satoh, Michihiro |
|
|
19 |
2 |
p. 294-302 |
artikel |
6 |
Effect of empagliflozin on plasma lipids and lipoproteins in type 2 diabetes and heart failure – Empire HF and SIMPLE
|
Emanuelsson, Frida |
|
|
19 |
2 |
p. 276-285 |
artikel |
7 |
Estimated stearoyl-CoA desaturase activity mediates the associations of total cysteine with adiposity: The Maastricht Study
|
Tore, Elena C. |
|
|
19 |
2 |
p. 348-357 |
artikel |
8 |
Exploring the impact of insurance switching on the cost-effectiveness of population genetic screening for familial hypercholesterolemia to US payers
|
Hendy, Lauren E. |
|
|
19 |
2 |
p. 310-319 |
artikel |
9 |
Ezetimibe-associated rhabdomyolysis: A comprehensive assessment of the USFDA adverse event reporting system using disproportionality analysis, case reviews, and meta-analysis of randomized clinical trials
|
Sridharan, Kannan |
|
|
19 |
2 |
p. 327-336 |
artikel |
10 |
Ezetimibe in the management of homozygous familial hypercholesterolaemia
|
Mansfield, Brett S. |
|
|
19 |
2 |
p. 320-326 |
artikel |
11 |
High burden of disease in patients with homozygous familial hypercholesterolemia despite recent advances in therapies and updated guidelines: A real-world study
|
Gu, Jing |
|
|
19 |
2 |
p. 303-309 |
artikel |
12 |
Impact of cumulative exposure to a high TG to HDL-C ratio on type 2 diabetes risk in young adults
|
Heo, Jung |
|
|
19 |
2 |
p. 267-275 |
artikel |
13 |
Implementation of guideline-based lipid reporting and rate of lipid lowering therapy prescription
|
Adhikari, Anish |
|
|
19 |
2 |
p. 358-363 |
artikel |
14 |
Lipidology: The time is now for specialty recognition
|
Willard, Kaye-Eileen |
|
|
19 |
2 |
p. 197-204 |
artikel |
15 |
Lipoprotein particle profile in the presence of peripheral artery disease among patients with coronary heart disease: Data from the CORDIOPREV study
|
de la Cruz-Ares, Silvia |
|
|
19 |
2 |
p. 256-266 |
artikel |
16 |
Managing hypercholesterolemia in adults older than 75 years without a history of atherosclerotic cardiovascular disease: An Expert Clinical Consensus from the National Lipid Association and the American Geriatrics Society
|
Bittner, Vera |
|
|
19 |
2 |
p. 215-237 |
artikel |
17 |
Niacin (Niacin) and clinical utility, don't be misled by recent niacin (Niacin) metabolite report
|
Superko, H. Robert |
|
|
19 |
2 |
p. 205-207 |
artikel |
18 |
Non-fasting triglyceride screening in volunteer blood donors: A pilot program
|
Abe, Caroline |
|
|
19 |
2 |
p. 369-371 |
artikel |
19 |
Nonlinearity of the inverse relationship between high-density lipoprotein (HDL) cholesterol and incident cardiovascular risk: Is it time to revisit the “HDL hypothesis”?
|
Hashem, Carl |
|
|
19 |
2 |
p. 238-246 |
artikel |
20 |
Omega-3 index improves upon the pooled cohort equation in predicting risk for CVD
|
Franco, William G. |
|
|
19 |
2 |
p. 286-293 |
artikel |
21 |
Oral semaglutide and reduction in major adverse cardiovascular events
|
Barton Duell, P. |
|
|
19 |
2 |
p. 195-196 |
artikel |
22 |
The association between lipoprotein(a) levels and the development of cardiac allograft vasculopathy
|
Abbas, Mohammed Tiseer |
|
|
19 |
2 |
p. 364-368 |
artikel |